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Accumulating evidence suggests that environmental cues modulate pathogenic processes in the CNS. However, without defining distinct cellular and molecular targets in the CNS, these observations will remain in the realm of pure correlation. Mechanistically, environmental triggers might be sensed by the immune system associated with the body's surface areas. Then, immune cells, which are motile, might traffic to the CNS and elicit responses in this compartment remote from their original site of activation. More recently, microbial products have been suggested to directly impact on microglial cells, the resident immune cells of the CNS, and control their morphology and function (Erny et al., 2015; Rothhammer et al., 2018) . In this issue of Cell, Wheeler et al. (2019) now take the next step and explore the concept that extrinsic compounds are directly sensed by CNS intrinsic cells. A bold idea at first glimpse, the descent of astrocytes from ectoderm, the germ layer that forms the lining tissues of the body with the outside world, may have imprinted in them traces of the machinery to respond to environmental cues.
Based on this rationale, Wheeler et al. establish a novel screening method of chemical compounds to test their effects on gene expression in glial cells (Figure 1 ). After preselecting a number of chemical compounds of the U.S. Environmental Protection Agency ToxCast database that were likely to modulate pathways known to be involved in inflammation and neurodegeneration, the authors directly add these compounds to zebrafish larvae exposed to lipopolysaccharide (LPS) and cuprizone (as a model of inflammatory demyelination in the CNS). Some of the compounds are shown to have the capacity to significantly modulate gene expression in GFP-labeled zebrafish radial glial cells and are validated to induce similar gene expression alterations in primary mouse astrocytes. The herbicide linuron is demonstrated to be a potent agent to induce NOS2 in astrocytes exposed to inflammatory stress. On the molecular level, linuron binds to the ligand-activated endoplasmic reticulum (ER) chaperone Sigmar1, which physically interacts with the kinase IRE1a and stabilizes the phosphorylated form of IRE1a. Phospho-IRE1a is a key initiator of the unfolded protein response (UPR) by splicing XBP1 mRNA to generate the active form of this transcription factor (Bettigole and Glimcher, 2015) . In vivo knockdown of XBP1 in astrocytes through a lentiviral approach decreases the expression of UPR target genes and, more importantly, ameliorates experimental autoimmune encephalomyelitis (EAE). Intraperitoneal injection of linuron in turn, exacerbates EAE-a process that is prevented when the molecular targets of the compound, i.e., Sigmar1 and XBP1, are ablated by in vivo CRISPR/ Cas9 technology. Downstream events of the UPR in astrocytes include the induction of the proinflammatory cytokine granulocyte macrophage colony-stimulating factor (GM-CSF), which increases the activation of microglial cells and augments infiltration of inflammatory monocytes. Finally, in brain tissue specimens of multiple sclerosis patients, the authors observe an activated UPR in inflammatory lesions but importantly also in normalappearing white and gray matter. In human biopsy samples, it is less clear than in the EAE paradigm whether astrocytes are the most relevant cellular source of the UPR.
The study by Wheeler et al. opens a new field of investigation to explore how environmental cues-such as toxic compounds or metabolites-modulate pathogenic cascades within the CNS. Besides an elegant novel screening approach, the possibility to directly manipulate and test potential molecular players in vivo using CRISPR/Cas9 constitutes a fundamental methodologic advance in understanding molecular pathways in glial cells in health and disease.
It can be expected that by these advanced methods, CNS-intrinsic cells, particularly astrocytes, will gain further attention and be better explored in a variety of disease contexts such as trauma, CNS malignancies, and neurodegenera-tion, but also chronic inflammation. Astrocytes are scaffolding cells of the CNS, and-at least in neuroinflammationhave long been considered either as unspectacular bystanders due to their limited capacity to present antigens to CD4+ T cells in vivo or as passive targets of an adaptive immune response such as in neuromyelitis optica where pathogenic antibodies bind to the astrocytic water channel aquaporin-4 (Mitsdoerffer et al., 2013) . Only recently, the metabolic support function of astrocytes for both neurons and oligodendroglial cells (Nave, 2010) and the cross-talk between astrocytes and microglial cells (Rothhammer et al., 2018; Vainchtein et al., 2018) , are being re-evaluated during brain development and diseases where dysregulated energy expenditure might contribute to loss of tissue function, such as primary degenerative CNS diseases, but also secondary progressive multiple sclerosis (Cambron et al., 2012) . Moreover, advances in ex vivo isolation techniques of astrocytes in combination with singlecell analyses reinvigorated the idea that ''reactive'' astrocytes might adopt distinct phenotypic states with distinct functions such as nuclear factor k light chain enhancer of activated B cells (NF-kB)-driven proinflammatory and neurotoxic astrocytes and STAT3 dependent astrocytes, which promote tissue repair and regeneration (Liddelow and Barres, 2017) .
Using the authors' approach, the next step might be to identify disease-associated pathways more specifically linked to the function of reactive astrocytes in various disease contexts. The UPR is a global stress response of cells that is triggered through accumulation of misfolded proteins in the ER. The UPR is controlled by the transcription factor ATF6 and the kinases PERK and IRE1a and results in a stop of translation and increased chaperone production to clear the block in protein folding or-if this is not successful-in apoptosis (Bettigole and Glimcher, 2015) . However, the UPR likely has been co-opted by astrocytes to control cellular programs that are independent of ER stress (Hetz et al., 2015) . Activation of UPR sensors by industrial chemical compounds may result in aberrant and detrimental astrocyte reactions. Probing CNS-intrinsic cells for disease-relevant molecular pathways. GFP-labeled radial glia of zebrafish larvae were probed for transcriptional responses to a library of chemical compounds. Candidate compounds were assayed in primary murine astrocytes for distinct molecular targets and downstream pathways before testing their effects in relevant disease models. For example, the herbicide linuron induces NOS2 in radial glial and a pro-in-flammatory transcriptional program in astrocytes by exploiting the UPR and exacerbates EAE. This experimental workflow renders CNS-intrinsic cells accessible to systematic perturbations to investigate distinct molecular pathways in health and disease.
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Many unresolved questions remain about the physiology and pathophysiology of CNS cells. One such question is whether direct sensing of environmental cues in the CNS is a causal event in chronic inflammatory or degenerative CNS diseases. Or, alternatively, pathology might be driven by CNS intrinsic processes, such as acquired or inborn errors of metabolism of CNS resident cells or by compartmentalized immune responses in the CNS parenchyma or meningeal space that are disconnected from the periphery. The study from Wheeler et al. illustrates how evolving techniques of experimental in vivo perturbation of CNS intrinsic cells may be a means to identify unexpected pathways in CNS cells and may help address these unresolved questions.
